Omnicell Price to Sales Ratio 2010-2024 | OMCL
Omnicell P/S Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
2024-05-03 | 30.13 | 1.24 | |
2024-03-31 | 29.23 | $24.23 | 1.21 |
2023-12-31 | 37.63 | $25.34 | 1.49 |
2023-09-30 | 45.04 | $27.21 | 1.66 |
2023-06-30 | 73.67 | $27.82 | 2.65 |
2022-12-31 | 50.42 | $27.90 | 1.81 |
2022-09-30 | 87.03 | $27.90 | 3.12 |
2022-06-30 | 113.75 | $26.78 | 4.25 |
2022-03-31 | 129.49 | $25.75 | 5.03 |
2021-12-31 | 180.44 | $24.88 | 7.25 |
2023-03-31 | 58.67 | $23.83 | 2.46 |
2021-09-30 | 148.43 | $23.05 | 6.44 |
2021-06-30 | 151.45 | $21.81 | 6.94 |
2021-03-31 | 129.87 | $21.29 | 6.10 |
2020-12-31 | 120.02 | $21.64 | 5.55 |
2020-09-30 | 74.66 | $21.25 | 3.51 |
2020-03-31 | 65.58 | $21.42 | 3.06 |
2019-12-31 | 81.72 | $20.95 | 3.90 |
2019-09-30 | 72.27 | $20.39 | 3.54 |
2019-06-30 | 86.03 | $19.75 | 4.36 |
2019-03-31 | 80.84 | $19.69 | 4.11 |
2018-12-31 | 61.24 | $19.62 | 3.12 |
2020-06-30 | 70.62 | $19.00 | 3.72 |
2018-09-30 | 71.90 | $19.39 | 3.71 |
2018-06-30 | 52.45 | $19.18 | 2.73 |
2018-03-31 | 43.40 | $19.18 | 2.26 |
2017-12-31 | 48.50 | $18.62 | 2.61 |
2017-09-30 | 51.05 | $18.30 | 2.79 |
2017-06-30 | 43.10 | $18.27 | 2.36 |
2017-03-31 | 40.65 | $18.36 | 2.21 |
2016-12-31 | 33.90 | $19.11 | 1.77 |
2016-09-30 | 38.30 | $17.90 | 2.14 |
2016-06-30 | 34.23 | $16.56 | 2.07 |
2016-03-31 | 27.87 | $14.80 | 1.88 |
2015-12-31 | 31.08 | $13.16 | 2.36 |
2015-09-30 | 31.10 | $12.93 | 2.40 |
2015-06-30 | 37.71 | $12.57 | 3.00 |
2015-03-31 | 35.10 | $12.39 | 2.83 |
2014-12-31 | 33.12 | $12.05 | 2.75 |
2014-09-30 | 27.33 | $11.68 | 2.34 |
2014-06-30 | 28.71 | $11.23 | 2.56 |
2014-03-31 | 28.62 | $11.01 | 2.60 |
2013-12-31 | 25.53 | $10.70 | 2.38 |
2013-09-30 | 23.68 | $10.38 | 2.28 |
2013-06-30 | 20.55 | $10.26 | 2.00 |
2013-03-31 | 18.88 | $9.81 | 1.92 |
2012-12-31 | 14.87 | $9.18 | 1.62 |
2012-09-30 | 13.90 | $8.39 | 1.66 |
2012-06-30 | 14.64 | $7.79 | 1.88 |
2012-03-31 | 15.21 | $7.39 | 2.06 |
2011-12-31 | 16.52 | $7.20 | 2.29 |
2011-09-30 | 13.78 | $7.06 | 1.95 |
2011-06-30 | 15.59 | $6.86 | 2.27 |
2011-03-31 | 15.24 | $6.70 | 2.28 |
2010-12-31 | 14.45 | $6.66 | 2.17 |
2010-09-30 | 13.08 | $6.65 | 1.97 |
2010-06-30 | 11.69 | $6.64 | 1.76 |
2010-03-31 | 14.03 | $6.65 | 2.11 |
2009-12-31 | 11.69 | $6.68 | 1.75 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.345B | $1.147B |
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $35.527B | 19.51 |
Inspire Medical Systems (INSP) | United States | $7.610B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.451B | 0.00 |
Axonics (AXNX) | United States | $3.424B | 0.00 |
10x Genomics (TXG) | United States | $3.133B | 0.00 |
Azenta (AZTA) | United States | $2.932B | 238.96 |
Olink Holding AB (publ) (OLK) | Sweden | $2.862B | 0.00 |
Enovis (ENOV) | United States | $2.859B | 21.19 |
Hims & Hers Health (HIMS) | United States | $2.622B | 0.00 |
Privia Health (PRVA) | United States | $2.184B | 96.89 |
Schrodinger (SDGR) | United States | $1.677B | 0.00 |
Phreesia (PHR) | United States | $1.255B | 0.00 |
Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
Standard BioTools (LAB) | United States | $0.734B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.701B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.635B | 0.00 |
Talkspace (TALK) | United States | $0.531B | 0.00 |
Health Catalyst (HCAT) | United States | $0.386B | 0.00 |
Pulmonx (LUNG) | United States | $0.361B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.331B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.319B | 0.00 |
Butterfly Network (BFLY) | United States | $0.192B | 0.00 |
P3 Health Partners (PIII) | United States | $0.189B | 0.00 |
Outset Medical (OM) | United States | $0.155B | 0.00 |
American Well (AMWL) | United States | $0.151B | 0.00 |
Augmedix (AUGX) | United States | $0.130B | 0.00 |
MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
TruBridge (TBRG) | United States | $0.125B | 5.32 |
111 (YI) | China | $0.094B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
NantHealth (NHIQ) | United States | $0.058B | 0.00 |
HeartBeam (BEAT) | United States | $0.058B | 0.00 |
Zepp Health (ZEPP) | China | $0.056B | 0.00 |
Movano (MOVE) | United States | $0.050B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
Akili (AKLI) | United States | $0.032B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.015B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
Biotricity (BTCY) | United States | $0.012B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Syra Health (SYRA) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |